Literature DB >> 15853660

Novel insights into c-Src.

O Alper1, E T Bowden.   

Abstract

Since identifying a transmissible agent responsible for tumorigenesis in chickens, the v-Src oncogene, significant progress has been made in determining the functions of its cellular homologue. c-Src is the product of the SRC gene and has been found both over-expressed and highly activated in a number of human cancers. In fact the relationship between c-Src activation and cancer progression is significant. Furthermore c-Src may play a role in the acquisition of the invasive and metastatic phenotype. In this review we will summarize some of the latest evidence for the role of c-Src in tumorigenesis and particularly in human tumor progression. In this review, specifically, we will address growth signals, adhesion, migration, invasion, angiogenesis and functional genomics.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15853660     DOI: 10.2174/1381612053507576

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  19 in total

Review 1.  Nonreceptor tyrosine kinases in prostate cancer.

Authors:  Yu-Ming Chang; Hsing-Jien Kung; Christopher P Evans
Journal:  Neoplasia       Date:  2007-02       Impact factor: 5.715

2.  Src tyrosine kinase regulates adhesion and chemotaxis in Waldenstrom macroglobulinemia.

Authors:  Hai T Ngo; Abdel Kareem Azab; Mena Farag; Xiaoying Jia; Molly M Melhem; Judith Runnels; Aldo M Roccaro; Feda Azab; Antonio Sacco; Xavier Leleu; Kenneth C Anderson; Irene M Ghobrial
Journal:  Clin Cancer Res       Date:  2009-09-15       Impact factor: 12.531

3.  The prognostic role of phospho-Src family kinase analysis in tongue cancer.

Authors:  Ofer Ben-Izhak; Victoria Cohen-Kaplan; Rafael M Nagler
Journal:  J Cancer Res Clin Oncol       Date:  2010-01       Impact factor: 4.553

4.  The bone marrow microenvironment in waldenstrom macroglobulinemia.

Authors:  Irene M Ghobrial; Patricia Maiso; Abdelkareem Azab; Yang Liu; Yong Zhang; Ghayas Issa; Feda Azab; Antonio Sacco; Phong Quang; Hai Ngo; Aldo Roccaro
Journal:  Ther Adv Hematol       Date:  2011-08

Review 5.  Bone sialoprotein and osteopontin in bone metastasis of osteotropic cancers.

Authors:  Thomas E Kruger; Andrew H Miller; Andrew K Godwin; Jinxi Wang
Journal:  Crit Rev Oncol Hematol       Date:  2013-09-07       Impact factor: 6.312

6.  The tyrosine kinase activity of c-Src regulates actin dynamics and organization of podosomes in osteoclasts.

Authors:  Olivier Destaing; Archana Sanjay; Cecile Itzstein; William C Horne; Derek Toomre; Pietro De Camilli; Roland Baron
Journal:  Mol Biol Cell       Date:  2007-10-31       Impact factor: 4.138

7.  Disruption of c-Jun reduces cellular migration and invasion through inhibition of c-Src and hyperactivation of ROCK II kinase.

Authors:  Xuanmao Jiao; Sanjay Katiyar; Manran Liu; Susette C Mueller; Michael P Lisanti; Anping Li; Timothy G Pestell; Kongming Wu; Xiaoming Ju; Zhiping Li; Erwin F Wagner; Tatsuo Takeya; Chenguang Wang; Richard G Pestell
Journal:  Mol Biol Cell       Date:  2008-01-23       Impact factor: 4.138

8.  Expression of Src and FAK in hepatocellular carcinoma and the effect of Src inhibitors on hepatocellular carcinoma in vitro.

Authors:  Grace M Lau; Gillian M Lau; Guo-Liang Yu; Irwin H Gelman; Alan Gutowski; David Hangauer; Jane W S Fang
Journal:  Dig Dis Sci       Date:  2008-11-01       Impact factor: 3.199

Review 9.  Tocotrienols: the emerging face of natural vitamin E.

Authors:  Chandan K Sen; Savita Khanna; Cameron Rink; Sashwati Roy
Journal:  Vitam Horm       Date:  2007       Impact factor: 3.421

10.  p66shc inhibits insulin-like growth factor-I signaling via direct binding to Src through its polyproline and Src homology 2 domains, resulting in impairment of Src kinase activation.

Authors:  Gang Xi; Xinchun Shen; David R Clemmons
Journal:  J Biol Chem       Date:  2010-01-04       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.